Patents by Inventor Moshe Mittelman

Moshe Mittelman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Erythropoietin for Enhancing Immune Responses and for Treatment of Lymphoproliferative Disorders
    Publication number: 20080233149
    Abstract: The present invention relates to the use of erythropoietin (EPO) for enhancing immune responses and for the treatment of lymphoproliferative disorders, excluding multiple myeloma. Accordingly to the invention EPO may be administered with a viral or bacterial vaccine.
    Type: Application
    Filed: July 12, 2005
    Publication date: September 25, 2008
    Applicants: YEDA RESEARCH AND DEVELOPMENT CO. LTD., MOR RESEARCH APPLICATIONS LTD.
    Inventors: Moshe Mittelman, Drorit Neumann
  • Pharmaceutical compositions comprising erythropoietin for treatment of cancer
    Publication number: 20030216316
    Abstract: Pharmaceutical compositions comprising erythropoietin are provided for treatment of cancer, particularly for treatment of multiple myeloma. Erythropoietin was found to be effective for inhibition of tumor growth, triggering of tumor regression, stimulation of the natural immunological defense against cancer and/or inhibition of cancer cell metastasis.
    Type: Application
    Filed: March 5, 2003
    Publication date: November 20, 2003
    Applicants: Yeda Research and Development Co. Ltd., MOR Research Applications Ltd.
    Inventors: Nechama Haran-Ghera, Moshe Mittelman, Alpha Peled
  • Pharmaceutical compositions comprising erythropoietin for treatment of cancer
    Patent number: 6579525
    Abstract: Pharmaceutical compositions comprising erythropoietin are provided for treatment of cancer, particularly for treatment of multiple myeloma. Erythropoietin was found to be effective for inhibition of tumor growth, triggering of tumor regression, stimulation of the natural immunological defense against cancer and/or inhibition of cancer cell metastasis.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: June 17, 2003
    Assignees: Yeda Research and Development Co. Ltd., Mor Research Applications Ltd.
    Inventors: Nechama Haran-Ghera, Moshe Mittelman, Alpha Peled